Endogenous Tissue Factor
Endogenous Tissue Factor - Related Videos
10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
0 Views •
Cited by 3 •
2024
This article outlines the protocol for quantifying the percentage of Tissue Factor (TF)-positive platelets using whole blood flow cytometry, assessing the protein: (1) intracellularly in resting conditions, and (2) on the cell surface, in both resting and activated conditions. Guidance is also provided for evaluating TF-positive platelets in platelet-rich plasma.
01:30
Factors Affecting Drug Distribution: Tissue Permeability
0 Views •
2025
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues. Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
05:35
Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
0 Views •
Cited by 5 •
2016
Here we report protocols to detect endogenous and exogenous centromere-kinetochore proteins in human cells and quantify these protein levels at centromeres-kinetochores by indirect immunofluorescent staining through the use of fixation (paraformaldehyde, acetone, or methanol fixation).
10:00
Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
0 Views •
Cited by 12 •
2015
Enzymatic microelectrode biosensors enable real-time measurements of extracellular cell signaling in biologically-relevant concentrations. The following protocols extend the applications of biosensors to the ex vivo and in vivo detection of ATP and H2O2 in the kidney.
01:27
Endogenous Growth Theory
0 Views •
2025
Economic growth has always intrigued leaders and economists. Older economic theories often saw technology as something that just appeared from outside the economy, without explanation. Endogenous Growth Theory changed that view. It says that growth comes from within, through people’s ideas, skills, and innovation. When individuals and businesses invest in education, research, and new technologies, they actively create the conditions for long-term economic growth.Rethinking Growth: From Capital...
FAQs
The separation of endogenous tissue factor from circulating blood normally limits contact with coagulation components. After vascular damage, exposure makes it available to bind factor VII/VIIa, initiating a localized coagulation response. This spatial control helps explain why tissue injury can be converted into hemostasis rather than continuous clotting under intact conditions.
Binding to factor VII/VIIa creates the tissue factor-factor VIIa complex, which activates factors IX and X. These downstream reactions support thrombin generation, followed by fibrin formation. Tracking this sequence clarifies how an initiating membrane signal is amplified into the molecular structure that stabilizes a developing clot.
Inflammation and cellular activation can increase endogenous tissue factor expression, while vascular damage can expose it to blood. These changes connect altered cellular states with coagulation rather than treating clot formation as an isolated vascular event. In biology, this link is important for understanding how tissue conditions can promote thrombin and fibrin production.
A useful investigation follows the chain from tissue injury, inflammation, or cellular activation to tissue factor exposure or upregulation, factor VII/VIIa binding, activation of factors IX and X, and eventual thrombin and fibrin production. Organizing observations in this sequence helps researchers identify where altered regulation may influence clot formation.
Because dysregulated tissue factor activity can contribute to cancer-associated coagulation, its study provides a way to connect cancer biology with abnormal clotting. The key question is not only whether coagulation occurs, but how altered tissue factor regulation may engage the factor VII/VIIa pathway and promote downstream thrombin and fibrin formation.
Analysis of endogenous tissue factor can help explain three related outcomes: normal hemostasis after injury, excessive clot formation in thrombosis, and coagulation changes associated with vascular disorders. Comparing these contexts focuses attention on regulation, exposure, and cellular activation, helping distinguish a protective response to damage from dysregulated activity that may become harmful.